C31H25FN8O2S — CID 155139868
(3S)-3-[[5-[2-cyclobutyl-5-(2-cyclopropylpyrimidin-5-yl)-1,3-thiazol-4-yl]-1,3,4-oxadiazol-2-yl]amino]-9-fluoro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one (PubChem CID 155139868) has the molecular formula C31H25FN8O2S and a molecular weight of 592.66 g/mol. Its IUPAC name is (3S)-3-[[5-[2-cyclobutyl-5-(2-cyclopropylpyrimidin-5-yl)-1,3-thiazol-4-yl]-1,3,4-oxadiazol-2-yl]amino]-9-fluoro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one.
| Compound Name | (3S)-3-[[5-[2-cyclobutyl-5-(2-cyclopropylpyrimidin-5-yl)-1,3-thiazol-4-yl]-1,3,4-oxadiazol-2-yl]amino]-9-fluoro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one |
|---|---|
| PubChem CID | 155139868 |
| Molecular Formula | C31H25FN8O2S |
| Molecular Weight | 592.66 g/mol |
| Exact Mass | 592.18 |
| IUPAC Name | (3S)-3-[[5-[2-cyclobutyl-5-(2-cyclopropylpyrimidin-5-yl)-1,3-thiazol-4-yl]-1,3,4-oxadiazol-2-yl]amino]-9-fluoro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one |
| SMILES | O=C1Nc2c(F)cccc2C(c2ccccc2)=N[C@@H]1Nc1nnc(-c2nc(C3CCC3)sc2-c2cnc(C3CC3)nc2)o1 |
| InChI | InChI=1S/C31H25FN8O2S/c32-21-11-5-10-20-22(16-6-2-1-3-7-16)35-27(28(41)36-23(20)21)38-31-40-39-29(42-31)24-25(43-30(37-24)18-8-4-9-18)19-14-33-26(34-15-19)17-12-13-17/h1-3,5-7,10-11,14-15,17-18,27H,4,8-9,12-13H2,(H,36,41)(H,38,40)/t27-/m1/s1 |
| InChIKey | BMVYJQOKMKFLET-HHHXNRCGSA-N |
| XLogP | 6.16 |
| TPSA | 131.08 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 43 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 592.66 |
| LogP ≤ 5 | 6.16 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |